Significantly lower levels of phosphorylated CREB, which cannot translocate to the nucleus to activate target genes, have also been reported in animal models of AD and TSEs [6,18] and in the hippocampus of AD patients [23]. Here, CREB1 is linked to Alzheimer disease.